title: Identification of novel pretranslational regulatory mechanisms for NF-κB activation.
abstract: NF-κB-controlled transcriptional regulation plays a central role in inflammatory and immune responses. Currently, understanding about NF-κB activation mechanism emphasizes IκB-tethered complex inactivation in the cytoplasm. In the case of NF-κB activation, IκB phosphorylation leads to its degradation, followed by NF-κB relocation to the nucleus and trans-activation of NF-κB-targeted genes. Pretranslational mechanism mediated NF-κB activation remains poorly understood. In this study, we investigated NF-κB pretranslational regulation by performing a series of database mining analyses and using six large national experimental databases (National Center of Biotechnology Information UniGene expressed sequence tag profile database, Gene Expression Omnibus database, Transcription Element Search System database, AceView database, and Epigenomics database) and TargetScan software. We reported the following findings: 1) NF-κB-signaling genes are differentially expressed in human and mouse tissues; 2) heart and vessels are the inflammation-privileged tissues and less easy to be inflamed because lacking in key NF-κB-signaling molecular expression; 3) NF-κB-signaling genes are induced by cardiovascular disease risk factors oxidized phospholipids and proinflammatory cytokines in endothelial cells; 4) transcription factors CCAAT/enhancer-binding proteins and NF-κB have higher binding site frequencies in the promoters of proinflammatory cytokine-induced NF-κB genes; 5) most NF-κB-signaling genes have multiple alternative promoters and alternatively spliced isoforms; 6) NF-κB family genes can be regulated by DNA methylation; and 7) 27 of 38 NF-κB-signaling genes can be regulated by microRNAs. Our findings provide important insight into the mechanism of NF-κB activation, which may contribute to cardiovascular disease, inflammatory diseases, and immunological disorders.
authors.affiliation: Cardiovascular Research Center, Department of Pharmacology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140, USA.
authors.forename: Xiao
authors.initials: X
authors.lastname: Huang
authors.forename: Ren
authors.initials: R
authors.lastname: Gong
authors.forename: Xinyuan
authors.initials: X
authors.lastname: Li
authors.forename: Anthony
authors.initials: A
authors.lastname: Virtue
authors.forename: Fan
authors.initials: F
authors.lastname: Yang
authors.forename: Irene H
authors.initials: IH
authors.lastname: Yang
authors.forename: Anh H
authors.initials: AH
authors.lastname: Tran
authors.forename: Xiao-Feng
authors.initials: XF
authors.lastname: Yang
authors.forename: Hong
authors.initials: H
authors.lastname: Wang
mesh_terms: D000818:Animals; D030541:Databases, Genetic; D005786:Gene Expression Regulation / Q000502:physiology*; D006801:Humans; D051379:Mice; D016328:NF-kappa B / Q000235:genetics / Q000378:metabolism*; D009928:Organ Specificity / Q000502:physiology; D015398:Signal Transduction / Q000502:physiology; D012984:Software
chemical_list: D016328:NF-kappa B
keywords: Cardiovascular Disease; Cardiovascular Disease Risk Factors; Cytokine; Gene Expression; Gene Expression Profile; NF-kappaB; NF-kappaB Activation; Pretranslational Mechanisms; Proinflammatory Cytokines; Translation